The latest addition to the inflammatory homeboys in chronic kidney disease: Interleukin-8

Nephron - Clinical Practice

Volumn 102, Issue 2, 2006, Pages

  Kalantar Zadeh, Kamyar ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; DIALYSIS; DISEASE ASSOCIATION; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MINIMUM INHIBITORY CONCENTRATION; NEPHRITIS; NOTE; PRIORITY JOURNAL; PROTEIN MALNUTRITION; RISK FACTOR; SURVIVAL RATE;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; INTERLEUKIN-8; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS;

EID: 30644464561     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088924     Document Type: Note

References (10)

1. United States Renal Data System: Excerpts from the USRDS 2004 Annual Data Report. Am J Kidney Dis 2005;45(suppl 1):S1-S28.
2. National Kidney Foundation I, Kidney-Dialysis Outcome Quality Initiative: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005:45.
3. Wrone EM, Hornberger JM, Zehnder JL, McCann LM, Coplon NS, Fortmann SP: Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol 2004;15:420-426.
4. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. Engl J Med 2005;353:238-248.
5. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808.
6. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H, Kopple JD, Greenland S: Revisiting outcome predictability of serum albumin in hemodialysis patients: time dependency, changes over time and population attributable fraction. Nephrol Dial Transplant 2005;20:1880-1888; doi: 10.1093/ndt/gfh941.
7. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimburger O, Cederholm T, Girndt M: IL-10, IL-6, and TNF-α: central factors in the altered cytokine network of uremia - the good, the bad, and the ugly. Kidney Int 2005;67:1216-1233.
8. Kalantar-Zadeh K, Kopple JD, Humphreys MH, Block G: Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant 2004;19:1507-1519.
9. Panichi V, Taccola D, Manca Rizza J, Consani C, Ghiadoni L, Filippi C, Cristofani R, Panicucci E, Migliori M, Sidoti A, Biagioli M, Boracelli M, Barsotti G, Tetta C: Interleukin-8 is a powerful prognostic predictor of all-cause and cardiovascular mortality in dialytic patients. Nephron 2006;102:c51-c58.
10. Moreau M, Brocheriou I, Petit L, Ninio E, Chapman MJ, Rouis M: Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque. Circulation 1999;99:420-426.